Related Experiment Video
Updated: Apr 16, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Emerging concepts in the therapy of mitochondrial disease
Carlo Viscomi1, Emanuela Bottani2, Massimo Zeviani1
1Unit of Molecular Neurogenetics, The Foundation "Carlo Besta" Institute of Neurology IRCCS, 20133 Milan, Italy; MRC-Mitochondrial Biology Unit, Cambridge CB2 0XY, UK.
Abstract:
Mitochondrial disorders are an important group of genetic conditions characterized by impaired oxidative phosphorylation. Mitochondrial disorders come with an impressive variability of symptoms, organ involvement, and clinical course, which considerably impact the quality of life and quite often shorten the lifespan expectancy. Although the last 20 years have witnessed an exponential increase in understanding the genetic and biochemical mechanisms leading to disease, this has not resulted in the development of effective therapeutic approaches, amenable of improving clinical course and outcome of these conditions to any significant extent. Therapeutic options for mitochondrial diseases still remain focused on supportive interventions aimed at relieving complications. However, new therapeutic strategies have recently been emerging, some of which have shown potential efficacy at the pre-clinical level. This review will present the state of the art on experimental therapy for mitochondrial disorders.
Insights
Mitochondrial disorders, genetic conditions impairing energy production, have limited treatments. This review explores emerging experimental therapies showing promise for these debilitating diseases.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Mitochondrial disorders are genetic conditions affecting oxidative phosphorylation.
- These disorders present with diverse symptoms, impacting quality of life and lifespan.
- Despite advances in understanding genetic and biochemical causes, effective treatments remain limited.
Purpose of the Study:
- To review the current landscape of experimental therapies for mitochondrial disorders.
- To highlight emerging therapeutic strategies and their pre-clinical findings.
Main Methods:
- Literature review of recent research on mitochondrial disorder therapies.
- Analysis of pre-clinical data for emerging therapeutic approaches.
Main Results:
- Current treatments are primarily supportive, managing complications.
- New therapeutic strategies are showing promise at the pre-clinical level.
- Significant progress in understanding disease mechanisms has not yet translated to broad clinical success.
Conclusions:
- Experimental therapies offer new hope for mitochondrial disorders.
- Further research is needed to translate pre-clinical promise into clinical efficacy.
- The review provides an overview of the state-of-the-art in experimental mitochondrial disease treatment.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Mitochondria
The Inner Mitochondrial Membrane
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Animal Mitochondrial Genetics

